- Home
- ACDC vs CSTL Comparison
ACDC vs CSTL Comparison
Compare ACDC & CSTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACDC
- CSTL
- Stock Information
- Founded
- ACDC 2014
- CSTL 2007
- Country
- ACDC United States
- CSTL United States
- Employees
- ACDC N/A
- CSTL N/A
- Industry
- ACDC Oilfield Services/Equipment
- CSTL Medical Specialities
- Sector
- ACDC Energy
- CSTL Health Care
- Exchange
- ACDC Nasdaq
- CSTL Nasdaq
- Market Cap
- ACDC 1.1B
- CSTL 946.1M
- IPO Year
- ACDC 2022
- CSTL 2019
- Fundamental
- Price
- ACDC $7.67
- CSTL $29.05
- Analyst Decision
- ACDC Hold
- CSTL Strong Buy
- Analyst Count
- ACDC 5
- CSTL 7
- Target Price
- ACDC $7.75
- CSTL $37.57
- AVG Volume (30 Days)
- ACDC 661.0K
- CSTL 451.3K
- Earning Date
- ACDC 11-05-2024
- CSTL 11-04-2024
- Dividend Yield
- ACDC N/A
- CSTL N/A
- EPS Growth
- ACDC N/A
- CSTL N/A
- EPS
- ACDC N/A
- CSTL 0.21
- Revenue
- ACDC $2,225,300,000.00
- CSTL $311,878,000.00
- Revenue This Year
- ACDC N/A
- CSTL $49.05
- Revenue Next Year
- ACDC $24.54
- CSTL N/A
- P/E Ratio
- ACDC N/A
- CSTL $137.24
- Revenue Growth
- ACDC N/A
- CSTL 62.43
- 52 Week Low
- ACDC $5.16
- CSTL $16.97
- 52 Week High
- ACDC $9.75
- CSTL $35.84
- Technical
- Relative Strength Index (RSI)
- ACDC 57.80
- CSTL 38.37
- Support Level
- ACDC $6.42
- CSTL $27.24
- Resistance Level
- ACDC $7.59
- CSTL $29.02
- Average True Range (ATR)
- ACDC 0.44
- CSTL 1.89
- MACD
- ACDC 0.05
- CSTL -0.63
- Stochastic Oscillator
- ACDC 72.78
- CSTL 13.95
About ACDC ProFrac Holding Corp.
ProFrac Holding Corp is engaged in providing hydraulic fracturing, completion services, and other complementary products and services to upstream oil and gas companies engaged in the exploration and production of North American unconventional oil and natural gas resources. Its operations are focused in West Texas, East Texas/Louisiana, South Texas, Oklahoma, Uinta, and Appalachian. The company operates in three segments: stimulation services, manufacturing, and proppant production. Stimulation services, which generate the majority of the revenue for the company operate a fleet of mobile hydraulic fracturing units and other auxiliary equipment that generates revenue by providing stimulation services.
About CSTL Castle Biosciences Inc.
Castle Biosciences Inc is a commercial-stage dermatological cancer company. It is focused on providing physicians and their patients with personalized, clinically actionable genomic information to make more accurate treatment decisions. The product portfolio of the company includes Cutaneous Melanoma, DecisionDx-Melanoma, DecisionDx-CMSeq, and DecisionDx-PRAME among others.